# Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer

Source: https://onco.cc/trials/nct01594879/  
OnCo record `nct01594879` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Progestins in Endometrial cancer, run by Korean Gynecologic Oncology Group, with a status the registry has not verified recently.

## Summary

Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer is a phase 2 interventional study registered as NCT01594879 by Korean Gynecologic Oncology Group, with 39 participants planned, started 2012-01 and due to reach its primary completion in 2014-12. Interventions recorded: MIrena(LNG-IUS), oral MPA. Conditions recorded: Endometrial Cancer.

Linked to the drug Progestins because the registry names it among its interventions and Endometrial cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01594879
- Phase: 2
- Setting: Treatment With Medroxyprogesterone Acetate(MPA) Plus Levonorgestrel-releasing Intrauterine System(LNG-IUS) in Young Women With Early Stage Endometrial Cancer: Multicenter Study: Korean Gynecologic Oncology Group Study (KGOG2009)
- Sponsor: Korean Gynecologic Oncology Group
- Enrolled: 39

## Sources

- ClinicalTrials.gov NCT01594879: https://clinicaltrials.gov/study/NCT01594879

## Connected records

- cancers: [Endometrial cancer](https://onco.cc/cancers/endometrial/)
- drugs: [Progestins (megestrol acetate, medroxyprogesterone, levonorgestrel IUD)](https://onco.cc/drugs/megestrol-progestins/)

---
JSON: https://onco.cc/api/v1/entities/nct01594879.json